Mode of Patient Sexual Orientation and Gender Identity Disclosure and Receipt of Tailored Cancer Resources
In this cross-sectional study of SOGI disclosure and use, few LGBTQ+ cancer survivors received tailored clinical resources despite high rates of SOGI disclosure. Clinical use of SOGI information remained limited, especially when it was not collected systematically. Efforts should prioritize both safe SOGI data collection and its integration into patient-centered care.
Authors
- Charles Stewart Kamen (ORCID: https://orcid.org/0000-0002-4219-4320)
- Austin R. Waters (ORCID: https://orcid.org/0000-0002-9947-8535)
- Megan A. Mullins (ORCID: https://orcid.org/0000-0003-2753-9068)
- NFN Scout (ORCID: https://orcid.org/0000-0001-5485-6152)
- Victor Basil
Institutions
- University of North Carolina at Chapel Hill (US)
- Providence College (US)
- University of Rochester Medical Center (US)
- Southwestern Medical Center (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.38809
- Primary Topic
- LGBTQ Health, Identity, and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- Gilead Sciences
- Servier
- Genentech